198 related articles for article (PubMed ID: 23471847)
1. Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicity.
Andersen BM; Pluhar GE; Seiler CE; Goulart MR; SantaCruz KS; Schutten MM; Meints JP; O'Sullivan MG; Bentley RT; Packer RA; Thomovsky SA; Chen AV; Faissler D; Chen W; Hunt MA; Olin MR; Ohlfest JR
Cancer Res; 2013 May; 73(10):2987-97. PubMed ID: 23471847
[TBL] [Abstract][Full Text] [Related]
2. Characterization of immune cell infiltration into canine intracranial meningiomas.
Boozer LB; Davis TW; Borst LB; Zseltvay KM; Olby NJ; Mariani CL
Vet Pathol; 2012 Sep; 49(5):784-95. PubMed ID: 21987303
[TBL] [Abstract][Full Text] [Related]
3. Intracranial meningioma in dogs and cats: a comparative review.
Sessums K; Mariani C
Compend Contin Educ Vet; 2009 Jul; 31(7):330-9. PubMed ID: 19746352
[TBL] [Abstract][Full Text] [Related]
4. Canine and feline intracranial meningiomas: an updated review.
Motta L; Mandara MT; Skerritt GC
Vet J; 2012 May; 192(2):153-65. PubMed ID: 22104505
[TBL] [Abstract][Full Text] [Related]
5. Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK.
Giles AJ; Hao S; Padget M; Song H; Zhang W; Lynes J; Sanchez V; Liu Y; Jung J; Cao X; Fujii R; Jensen R; Gillespie D; Schlom J; Gilbert MR; Nduom EK; Yang C; Lee JH; Soon-Shiong P; Hodge JW; Park DM
JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31536478
[TBL] [Abstract][Full Text] [Related]
6. Multiple meningiomas in three dogs.
McDonnell JJ; Kalbko K; Keating JH; Sato AF; Faissler D
J Am Anim Hosp Assoc; 2007; 43(4):201-8. PubMed ID: 17615400
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional conformal radiation therapy alone or in combination with surgery for treatment of canine intracranial meningiomas.
Keyerleber MA; McEntee MC; Farrelly J; Thompson MS; Scrivani PV; Dewey CW
Vet Comp Oncol; 2015 Dec; 13(4):385-97. PubMed ID: 23869984
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the humoral response of meningioma patients to possible common tumour-associated antigens.
Mottet S; Martin-Achard A; de Tribolet N; Diserens AC
Acta Neurochir (Wien); 1980; 52(1-2):19-25. PubMed ID: 7376941
[TBL] [Abstract][Full Text] [Related]
9. Unusual features in four canine meningiomas.
Schöniger S; Woolford L; Jutras L; Head E; de Lahunta A; Summers BA
J Comp Pathol; 2013; 149(2-3):237-41. PubMed ID: 23660088
[TBL] [Abstract][Full Text] [Related]
10. Development of an autologous canine cancer vaccine system for resectable malignant tumors in dogs.
Yannelli JR; Wouda R; Masterson TJ; Avdiushko MG; Cohen DA
Vet Immunol Immunopathol; 2016 Dec; 182():95-100. PubMed ID: 27863558
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma.
Kamstock D; Elmslie R; Thamm D; Dow S
Cancer Immunol Immunother; 2007 Aug; 56(8):1299-309. PubMed ID: 17502972
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of progesterone and estrogen receptor expression in 15 meningiomas of dogs and cats.
Adamo PF; Cantile C; Steinberg H
Am J Vet Res; 2003 Oct; 64(10):1310-8. PubMed ID: 14596471
[TBL] [Abstract][Full Text] [Related]
13. [Malignant meningioma with lung metastases in a Boxer].
Schmidt P; Geyer C; Hafner A; Bise K; Hermanns W
Tierarztl Prax; 1991 Jun; 19(3):315-9. PubMed ID: 1887446
[TBL] [Abstract][Full Text] [Related]
14. What is your diagnosis? Cystic meningioma.
Johnson LM; Hecht S; Arendse AU; Adams WH
J Am Vet Med Assoc; 2007 Sep; 231(6):861-2. PubMed ID: 17867966
[No Abstract] [Full Text] [Related]
15. Intracranial meningioma: a comparative pathologic study of 28 dogs.
Patnaik AK; Kay WJ; Hurvitz AI
Vet Pathol; 1986 Jul; 23(4):369-73. PubMed ID: 3750730
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Dysregulation in Canine Meningioma: RT-qPCR Analysis of Formalin-Fixed Paraffin-Embedded Samples.
Foiani G; Guelfi G; Mandara MT
J Neuropathol Exp Neurol; 2021 Sep; 80(8):769-775. PubMed ID: 34272938
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin Receptor 2 Expression in Canine Meningioma.
Foiani G; Guelfi G; Chiaradia E; Mancini F; Trivelli C; Vitellozzi G; Lepri E; Mandara MT
J Comp Pathol; 2019 Jan; 166():59-68. PubMed ID: 30691608
[TBL] [Abstract][Full Text] [Related]
18. The immune response to disialoganglioside GD3 vaccination in normal dogs: a melanoma surface antigen vaccine.
Milner RJ; Salute M; Crawford C; Abbot JR; Farese J
Vet Immunol Immunopathol; 2006 Dec; 114(3-4):273-84. PubMed ID: 17027091
[TBL] [Abstract][Full Text] [Related]
19. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived dendritic cell vaccination of dogs with naturally occurring melanoma by using human gp100 antigen.
Gyorffy S; Rodriguez-Lecompte JC; Woods JP; Foley R; Kruth S; Liaw PC; Gauldie J
J Vet Intern Med; 2005; 19(1):56-63. PubMed ID: 15715049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
